Comparison between Neochem Bio IPO and ScaleSauce IPO.
Neochem Bio IPO is a SME Bookbuilding IPO proposed to list at NSE SME while ScaleSauce IPO is a SME Bookbuilding proposed to list at NSE SME.
| Neochem Bio IPO | ScaleSauce IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Vivro Financial Services Pvt.Ltd. | 3Dimension Capital Services Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Rikhav Securities Ltd. | Alacrity Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Neochem Bio IPO is up to ₹42.69 Cr whereas the issue size of the ScaleSauce IPO is up to ₹38.20 Cr. The final issue price of Neochem Bio IPO is ₹98.00 per share and of ScaleSauce IPO is ₹107.00 per share.
| Neochem Bio IPO | ScaleSauce IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹93.00 per share | ₹101.00 per share |
| Issue Price (Upper) | ₹98.00 per share | ₹107.00 per share |
| Issue Price (Final) | ₹98.00 per share | ₹107.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1200 shares |
| Fresh Issue Size | 43,56,000 shares | 35,70,000 shares |
| Fresh Issue Size (Amount) | up to ₹42.69 Cr | up to ₹38.20 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 43,56,000 shares | 35,70,000 shares |
| Issue Size Total (Amount) | up to ₹42.69 Cr | up to ₹38.20 Cr |
Neochem Bio IPO opens on Dec 02, 2025, while ScaleSauce IPO opens on Dec 05, 2025. The closing date of Neochem Bio IPO and ScaleSauce IPO is Dec 04, 2025, and Dec 09, 2025, respectively.
| Neochem Bio IPO | ScaleSauce IPO | |
|---|---|---|
| Anchor Bid Date | Dec 01, 2025 | Dec 04, 2025 |
| Issue Open | Dec 02, 2025 | Dec 05, 2025 |
| Issue Close | Dec 04, 2025 | Dec 09, 2025 |
| Basis Of Allotment (Tentative) | Dec 05, 2025 | Dec 10, 2025 |
| Initiation of Refunds (Tentative) | Dec 08, 2025 | Dec 11, 2025 |
| Credit of Share (Tentative) | Dec 08, 2025 | Dec 11, 2025 |
| Listing date (Tentative) | Dec 09, 2025 | Dec 12, 2025 |
| Anchor Lockin End date 1 | Jan 04, 2026 | Jan 09, 2026 |
| Anchor Lockin End date 2 | Mar 05, 2026 | Mar 10, 2026 |
Neochem Bio IPO P/E ratio is 15.85, as compared to ScaleSauce IPO P/E ratio of 10.33.
| Neochem Bio IPO | ScaleSauce IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Neochem Bio Solutions Ltd.'s revenue increased by 39% and profit after tax (PAT) rose by 330% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Encompass Design India Ltd.'s revenue increased by 37% and profit after tax (PAT) rose by 57% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 91.12 | 80.19 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.7 | 58.93 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 15.85 | 10.33 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹167.78 Cr. | ₹151.76 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 48.82% | 50.26% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 41.67% | 40.49% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.80 | 0.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.18 | ₹10.35 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 48.82% | 33.13% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Neochem Bio IPO Retail Individual Investors (RII) are offered 15,26,400 shares while in ScaleSauce IPO retail investors are offered 15,26,400 shares. Qualified Institutional Buyers (QIB) are offered 8,71,200 shares in Neochem Bio IPO and 7,14,000 shares in ScaleSauce IPO.
| Neochem Bio IPO | ScaleSauce IPO | |
|---|---|---|
| Anchor Investor Reservation | 13,03,200 shares | 10,69,200 shares |
| Market Maker Reservation | 2,32,800 shares | 1,88,400 shares |
| QIB | 8,71,200 shares | 7,14,000 shares |
| NII | 6,55,200 shares | 5,36,400 shares |
| RII | 15,26,400 shares | 12,50,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 43,56,000 shares | 35,70,000 shares |
Neochem Bio IPO subscribed 15.52x in total, whereas ScaleSauce IPO subscribed 2.19x.
| Neochem Bio IPO | ScaleSauce IPO | |
|---|---|---|
| QIB (times) | 21.97x | 1.25x |
| NII (times) | 21.15x | 4.60x |
| Big NII (times) | 25.78x | 5.73x |
| Small NII (times) | 11.88x | 2.29x |
| RII (times) | 9.42x | 1.69x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 15.52x | 2.19x |
